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ABSTRACT
SMG-9 is part of a protein kinase complex, SMG1C,
which consists of the SMG-1 kinase, SMG-8 and
SMG-9. SMG1C mediated phosphorylation of Upf1
triggers nonsense-mediated mRNA decay (NMD), a
eukaryotic surveillance pathway that detects and
targets for degradation mRNAs harboring prema-
ture translation termination codons. Here, we have
characterized SMG-9, showing that it comprises an
N-terminal 180 residue intrinsically disordered
region (IDR) followed by a well-folded C-terminal
domain. Both domains are required for SMG-1
binding and the integrity of the SMG1C complex,
whereas the C-terminus is sufficient to interact
with SMG-8. In addition, we have found that
SMG-9 assembles in vivo into SMG-9:SMG-9 and,
most likely, SMG-8:SMG-9 complexes that are not
constituents of SMG1C. SMG-9 self-association is
driven by interactions between the C-terminal
domains and surprisingly, some SMG-9 oligomers
are completely devoid of SMG-1 and SMG-8. We
propose that SMG-9 has biological functions
beyond SMG1C, as part of distinct SMG-9-
containing complexes. Some of these complexes
may function as intermediates potentially regulating
SMG1C assembly, tuning the activity of SMG-1 with
the NMD machinery. The structural malleability of
IDRs could facilitate the transit of SMG-9 through
several macromolecular complexes.
INTRODUCTION
Eukaryotic gene expression comprises a complex set of
biochemical reactions starting with the transcription
of the genetic information and ending in the synthesis of
proteins. Between these two events, post-transcriptional
modiﬁcations and remodelling are required to assemble
a mature mRNA that can be translated by the ribosome,
and several surveillance mechanisms ensure the ﬁdelity
and accuracy of these processes. Nonsense-mediated
mRNA decay (NMD) is a post-transcriptional surveil-
lance mechanism that, in eukaryotes, recognizes and
degrades mRNAs containing premature translation ter-
mination codons (PTCs) to prevent the accumulation of
potentially harmful truncated polypeptides encoding for a
truncated protein (1,2).
The NMD machinery marks a PTC-containing mRNA
for degradation through a highly sophisticated sequence
of protein-protein interactions involving different poly-
peptides (2,3). Until recently, seven conserved core
factors for NMD had been identiﬁed to be present in
most metazoan, SMG-1, Upf1, Upf2, Upf3, SMG-5,
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SMG-6 and SMG-7. Thanks to an intense current
research effort, a picture of the players and the molecular
mechanisms involved in NMD is starting to emerge (1,2).
Yet, many aspects remain obscure and several models
have been proposed to explain the molecular mechanisms
by which the NMD machinery tags an mRNA for degrad-
ation (4,5). An interesting debate in current literature
upholds a vision of NMD regulated by the outcome of a
competition between stimulating and downregulating
signals (3–6). In any case, the topic of what determines
the fate of a PTC-containing mRNA is still the subject
of open research (3,5,7).
One of the central players articulating the NMD
response is SMG-1, a large protein of roughly 430 kDa
that belongs to the phosphatidylinositol 3-kinase-related
protein kinase (PIKK) family of serine-threonine kinases
(8,9). SMG-1 is a component of mRNA surveillance
complexes and the phosphorylation of Upf1 by SMG-1
is the single essential event in metazoans to trigger all
the latter processes leading to the degradation of an
mRNA (10). A complex known as SURF
(SMG-1:Upf1:eRF1:eRF3) and containing SMG-1, Upf1
and the eukaryotic release factors eRF1 and eRF3 is
assembled on a termination codon together with the
ribosome (11–13). The ribosome:SURF complex can
interact with a downstream exon–junction-complex
(EJC), a protein complex deposited 20–24 nt upstream
the exon–exon junction, through the Upf2 and Upf3
proteins, activating the kinase activity of SMG-1 on
Upf1. Phospho-Upf1 is thought to recruit the
mRNA-decapping as well as the RNA-degrading machin-
ery that eventually degrades the mRNA containing the
PTC (2,3).
SMG-1 has been shown to play other roles besides
controlling NMD. Depletion of SMG-1 in human cells
inﬂuences the response to DNA damage (8,14) and regu-
lates the association of telomeric repeat-containing RNA
at telomeres (15). SMG-1 is required for adequate regula-
tion of p53 phosphorylation upon genotoxic and oxidative
stress and controls cell proliferation and apoptosis
(14,16–18). Although the molecular bases of all these
processes are unclear, many of these functional features
parallel those of other PIKKs, suggesting some cooper-
ation among the members of this family of kinases (8,13).
Very recently, two novel components of a SMG-1
complex have been discovered and named SMG-8 and
SMG-9 (12). These proteins were isolated due to their
co-puriﬁcation with SMG-1, with which they form a
stable complex (SMG-1:SMG-8:SMG-9), named
SMG1C. SMG-8 and SMG-9 are tightly associated with
SMG-1 and they seem to regulate its kinase activity and
the remodelling of the mRNA surveillance complex.
Interestingly, additional NMD factors, Ruvbl1, Ruvbl2,
RPB5 and SMG-10, have just been described, highlighting
the complexity of the NMD machinery (13). SMG-8 is a
991 amino acid protein which has been proposed to
regulate the correct localization of SMG-1 at the
PTC-stalled ribosome to form the SURF complex (12).
SMG-9 is a 520 amino acid protein comprising a central
putative nucleotide-triphosphatase domain. SMG-9 seems
to regulate the formation of the SMG-1:SMG-8:SMG-9
complex and probably up-regulates the kinase activity of
SMG-1 since SMG-1:SMG-9 complexes show higher
activity than SMG-1 (12). Both SMG-8 and SMG-9 are
required for mammalian NMD and the stable association
between these two proteins is an absolute requirement for
the inhibition of the NMD response until a genuine PTC is
recognized (12).
In order to improve our understanding of the functions
and molecular structure of the SMG1C complex, here we
have characterized SMG-9. We present evidence showing
that SMG-9 comprises two distinct domains. The
N-terminal domain is an intrinsically disordered region
(IDR) essential for the maintenance of the structural in-
tegrity of the SMG-1:SMG-8:SMG-9 complex. IDRs are a
hot topic of research, as they appear to provide the
essential speciﬁcity and malleability for the large macro-
molecular machines requiring multiple and variable
protein–protein interactions, as those functioning in all
stages of eukaryotic gene expression (19,20). Unexpec-
tedly, several experiments in vivo reveal that, besides is
participation as a component of the SMG1C complex,
SMG-9 can assembly as homodimers and, most likely,
SMG-8:SMG-9 heterodimers that could represent inter-
mediates regulating the assembly of the SMG1C complex.
MATERIALS AND METHODS
Prediction of ordered and disordered regions
We analysed the predicted ordered and disordered regions
in the sequences of SMG-1, SMG-8 and SMG-9 using one
of the most accepted predictors of naturally disordered
regions, PONDR (http://www.pondr.com) (21). The
default predictor VL-XT was used.
Cloning, expression and puriﬁcation of NT-SMG-912–180
NT-SMG-9 cDNA was subcloned between the EcoRI and
NcoI sites on modiﬁed N-terminal HisTag pRAT4, pRHO
and pGEX-6P-2 plasmids (GE Healthcare Bio-Sciences,
Buckinghamshire, UK). The initial GST fusion construct
was made comprising amino acids 1–180. After the obser-
vation of spontaneous self-cleavage in the initial
GST-fusion construct, the site of cleavage was identiﬁed
by mass spectroscopy and the construct re-cloned
comprising amino acids 12–180. All proteins were ex-
pressed in Escherichia coli strain BL21(DE3) and the ex-
pression detected in a soluble fraction after cell lysis by
sonication. GST-fusion proteins were puriEed with
GST-Trap columns (20ml, GE Healthcare Bio-Sciences)
and NT-SMG-9 was isolated from GST after digestion
with the 3C protease. A second GST-trap column
followed by a cation exchange chromatography in
SP-sepharose HiTrap colum (5ml, GE Healthcare
Bio-Sciences) followed by a ﬁnal step of gel-Eltration
chromatography (Sephacryl S-100, GE Healthcare
Bio-Sciences) yielded a highly pure preparation as
judged by SDS–PAGE after Coomassie brilliant blue
staining. Protein concentration was determined by UV
absorption at 280 nm. The protein solutions were
concentrated with an Amicon Ultra device (Millipore,
Bedford, MA, USA). Mass spectroscopy was used to
348 Nucleic Acids Research, 2011, Vol. 39, No. 1
 at Centro de Inform
aciÃ³n y DocumentaciÃ³n CientÃ-fica on December 15, 2014
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
assess the identity as well as the purity of ﬁnal
preparations.
Spectroscopic techniques
Circular dichroism (CD) spectra were recorded on a
JASCO J-805 spectropolarimeter. An optical cuvette
with a 1-mm path length was used. The temperature of
the measuring cell was maintained at 25C. Spectra were
collected in a spectral range of 200–250 nm with a
path-length of 1 nm. The NT-SMG-9 preparation was
dissolved in 20mM sodium phosphate (pH 7.2) and
50mM NaCl at a concentration of 15 mM. Data was
analysed using the software KD2.
Fluorescence spectra were acquired on an F-4500
Fuorescence spectrophotometer (Hitachi, Tokyo, Japan)
at 25C. The concentration of NT-SMG-9 was 15 mM.
Buffer solution contained 20mM sodium phosphate
(pH 7.2) and 50mM NaCl. The excitation wavelength
was 295 nm, and the emission spectra were recorded
between 285 and 500 nm. Denaturing conditions
involved the measurement with the same conditions
buffer and protein concentration but in the presence of
6M guanidinium hydrochloride (Pierce).
In the NMR spectroscopy experiments, samples for 1H
monodimensional spectra were prepared in 20mM sodium
phosphate (pH 7.2) and 50mM NaCl at a concentration
of 100 mM. 15N-labelled samples were prepared in M9
medium at a concentration of 200 mM. The NMR
samples contained 10% D2O.The monodimensional as
well as 1H–15N heteronuclear single-quantum correlation
(HSQC) spectra were acquired at 25C on a Bruker
DMX-600 spectrometer equipped with a cryoprobe.
For reagents (antibodies)
Anti-SMG-8 and -SMG-1 have been described earlier
[Yamashita et al. (12)]. Anti-HA (clone 3F10) (Roche),
anti-SBP (SantaCruz), anti-mTOR (Cell Signaling
Technology), anti-aPKC (C-20) (SantaCruz) were
obtained commercially.
Afﬁnity puriﬁcation, immunoprecipitation and
western blot analysis
pEF_Flag-HA-SBP-SMG-9 (2–520) (for Figure 5B),
pEF_Flag-HA-SBP-NT-SMG-9 (2–181), pEF_Flag-
HA-SBP-CT1-SMG-9 (185–520), pEF_Flag-HA-SBP-
CT2-SMG-9 (175–520), pcDNA5/NTAP(CBP-SBP)-
SMG-9 (2–520) (for Figure 5C), pSR_Strep-HA-SMG-9
full (2–520), pSR-V5-SMG-9 full (2–520), pSR_V5-
NT-SMG-9 (2–181) and pSR-V5-CT-SMG-9 (182–520)
were constructed by cloning each cDNA fragment by
standard methods. siLentGene-puro-siSMG-9UTR
(siRNA sequence targeted to the 30-UTR of the SMG-9
mRNA: GGAGAGGAATGTCATGCAC) was con-
structed by method described in manual.
A 293T cells were transfected using HEKfectin
(Biorad), and lysed with a loose-ﬁt Potter–Elvehjem hom-
ogenizer in T-buffer [20mM HEPES–NaOH at pH 7.5,
50mM NaCl, 0.05% Tween-20, 2.5mM MgCl2, 0.5mM
DTT, protease inhibitor cocktail (Roche), phosphatase in-
hibitor cocktail (Roche) and 100mg/ml RNaseA (Qiagen)].
The soluble fractions were pre-cleared with sepharose 4B
(Sigma) and then incubated with streptavidin–sepharose
(GE Biotech) for 2 h at 4C with gentle rotation.
Pre-cleared lysates were incubated with streptavidin–
sepharose or anti-V5 antibodies for 2 h or 1 h at 4C
with gentle rotation. For antibodies, subsequently, the
soluble fractions were incubated with 30 ml of protein G
sepharose (GE Biotech) for an additional 1 h at 4C with
gentle rotation. After washing with RNase() T-lysis
buffer, the afﬁnity-puriﬁed protein complexes were
eluted by incubation at 4C for 30min with RNase()
lysis buffer containing 2mM biotin (Sigma) or SDS
sample buffer, respectively. All proteins in western blot
experiments were detected with an ECL western blot
detection kit (GE Biotech) or Lumi-Light (Roche). All
experiments were performed two to three times, and
typical results are shown.
Size exclusion chromatography of SMG-9 complexes
For the preparation of HeLa cell extracts for gel column
fractionation, 3 108 HeLa cells were re-suspended in an
equal volume of lysis buffer containing 10mM Tris–HCl
at pH 8.0, 150mM NaCl, 0.4% NP40, 2mM MgCl2,
0.2mM DTT, 0.1mM PMSF, 100 nM Okadaic acid and
200 mg/ml RNaseA. After incubation on ice for 10min,
cells were lysed by 15 hand-strokes of a loose-ﬁt
Potter-Elvehjem homogenizer. The cell lysate was
centrifuged at 15 000g for 30min, and the supernatant
was loaded onto a 24ml Superose 6 FPLC column (GE
Biotech) equilibrated with lysis buffer. Fractions (400 ml)
were collected from 5 to 24ml elution volume. Fractions
were pooled and concentrated. Proteins were detected
by western blotting. A control molecular marker was
obtained by running the proteins thyroglobulin
(669 kDa), ferritin (440 kDa), catalase (232 kDa),
aldolase (158 kDa), and RNaseA (15 kDa) (GE Biotech)
on the same column under the same conditions.
RESULTS
SMG-9 comprises two distinct structural domains
The ﬁrst description of SMG-9 reported the presence of a
putative nucleotide-triphosphatase domain comprising
residues 181–520 (12). We now performed a more
thorough analysis of the SMG-9 sequence using several
bioinformatic methods, which revealed the presence of
an unusual N-terminal region. The N-terminal region of
SMG-9 was enriched in prolines, polar and charged
residues while showing a low content in the hydrophobic
residues that most frequently form the hydrophobic core
of conventional protein domains (Supplementary Figure
S1). These features are the signature of intrinsically dis-
ordered regions (IDRs), segments of proteins that under
native conditions do not fall into a conventional fold and
which participate in speciﬁc binding to targets in highly
complex multi-component macromolecular machines (19).
We searched for the presence of IDRs in SMG-9 based on
the distinctive signature of their sequence composition and
conservation of amino acids. Several in silico disordered
predictors have been developed, all of them showing
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excellent predictive value (19,20). We used PONDR
(‘Predictor Of Natural Disordered Regions’)
(http://www.pondr.com/) (21) to look for potential dis-
ordered domains in SMG-9. SMG-9 exhibited two
clearly distinct regions in its primary structure
(Figure 1A). A C-terminal region comprising residues
181–520 was predicted to conform to a conventional
well-folded domain in agreement with its description as
a putative NTPase domain based on sequence homology
(CT-SMG-9 from now on). In contrast, PONDR pre-
dicted a large highly disordered region encompassing the
ﬁrst 180 residues of SMG-9 (NT-SMG-9 from now on)
(Figure 1A).
Disordered regions typically exhibit a higher ratio
between the sum of polar plus charged amino acids and
the hydrophobic residues than structured folded domains,
since they do not form a conventional hydrophobic core.
An analysis of the distribution of different types of amino
acids in SMG-9 revealed a propensity of NT-SMG-9
towards polar and charged amino acids (Figure 1B),
whereas the C-terminal domain of SMG-9 showed a
higher proportion of hydrophobic residues (Figure 1C).
Also, a comparison of the ratio between hydrophobicity
versus net charge in several proteins placed the NT-SMG-
9 domain well within the group of other known intrinsic-
ally unstructured proteins whereas the C-terminal domain
showed the characteristic pattern of folded domains
(Supplementary Figure S2).
The recombinant N-terminus of SMG-9 is a 20 kDa
soluble monomeric domain
To further analyse the biophysical and structural
properties of the NT-SMG-9 domain, several milligrams
of highly pure protein were required, only achievable by
recombinant production. Non-speciﬁc degradation of par-
tially folded heterologous proteins expressed in
Escherichia coli is a common problem, which could be
potentially enhanced in the case of an IDR, due to its
intrinsic disordered structure. To increase the chances of
success in the production of NT-SMG-9 in E. coli, we set
up three parallel strategies taking advantage of this
well-established prokaryotic system. We cloned the
cDNA corresponding to the ﬁrst 180 residues of SMG-9
(NT-SMG-9) into three different expression plasmids con-
taining either (i) a N-terminal hexahistidine tag (HisTag),
(ii) a N-terminal OmpA peptide inducing the secretion of
the expressed protein to the periplasmic space and a
C-terminal HisTag and (iii) a fusion protein with a gluta-
thione synthetase transferase (GST) and a site for the 3C
protease between the GST and the target construct to
remove the tag. We found no expression when using the
N-terminal HisTag, whereas a small secretion of the ex-
pressed protein was observed with the periplasmic
secretion-inducing vector, albeit with a high degree of
non-speciﬁc degradation (not shown, see below and
Figure 2A for the puriﬁcation of NT-SMG-912–180). The
best results were obtained with the fusion construct con-
taining a GST tag. In standard conditions, GST-NT-
SMG-9 was expressed as a soluble protein, but 20–30%
of the recovered protein from the GST column was
non-speciﬁcally proteolysed. We identiﬁed the non-speciﬁc
cleavage site by sequencing of the N-terminus and by
mass spectrometry of the spontaneous truncated
product. We found that the ﬁrst 11 amino acids of
NT-SMG-9 were removed non-speciﬁcally during puriﬁ-
cation and we therefore recloned the fragment with-
out these residues in the GST vector to produce a
more stable product. This construct, GST-NT-SMG-
912–180, missing the ﬁrst 11 amino acids, expressed as a
soluble protein and was entirely stable after perform-
ing the puriﬁcation steps described earlier (Figure 2A).
The ﬁnal steps during the puriﬁcation protocol
involved a second GST afﬁnity column to remove the
GST-tag, an intermediate step of cationic exchange
and a ﬁnal gel ﬁltration chromatography (Figure 2B).
This protocol allowed the efﬁcient production of soluble
NT-SMG-912–180 with a yield of 3–4mg of protein per
liter of medium (Figure 2C).
We characterized the hydrodynamic behaviour of
E. coli expressed NT-SMG-912–180 protein in solution to
NT-SMG-9
1                     180 181                               520
O
rd
er
D
is
o
rd
er
Residue Number
1.0
0.8
0.6
0.4
0.2
0.0
0.5
PO
ND
R 
Sc
o
re
0 100 200 300 400 500
Polar
NT-SMG-9
A
B C CT-SMG-9
Charged Hydroph. Polar Charged Hydroph.
CT-SMG-9
(NTPs-like)
50
40
30
20
10
0
Pe
rc
en
ta
ge
Figure 1. Analysis of SMG-9 primary structure. (A) PONDR analysis
of the SMG-9 amino acid sequence. A PONDR score >0.5 predicts
those amino acids belonging to a disordered region. A stretch of dis-
ordered amino acids of more than 50 residues are usually considered a
disordered domain. This analysis revealed that the sequence of SMG-9
could be divided in two regions: an N-terminal 180 residue intrinsically
disordered region and a C-terminal folded domain, encoding a putative
nucleotide-triphosphatase (NTPase)-like domain (12). Distribution of
types of amino acid in NT-SMG-9 (B) and the C-terminal region of
SMG-9 (C). NT-SMG-9 revealed a propensity towards polar and
charged amino acids while the C-terminal domain was enriched in
hydrophobic residues. Unstructured domains frequently exhibit a low
content in hydrophobic amino acids and a bias towards charged and
polar residues.
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deﬁne its state of aggregation using analytical gel ﬁltration
and analytical ultracentrifugation (Supplementary Figure
S3). NT-SMG-912–180 eluted as a single sharp peak in size
exclusion chromatography, with a retention volume of
1.72ml, compatible with a molecular mass of 20 kDa
after calibration of the column (Supplementary Figure
S3A). Less than 5% of the protein eluted as a large aggre-
gate in the void volume, indicating that NT-SMG-912–180
behaved as expected for a single monomeric species in
solution. This experiment was performed in medium-high
ionic strength conditions (300mM NaCl) that were
required to avoid interaction of the protein with the
column matrix. In addition, ultracentrifugation ana-
lysis at lower ionic strength conditions (50mM NaCl)
performed through sedimentation velocity experiments
(Supplementary Figure S3B) unambiguously showed that
NT-SMG-912–180 behaved as a single species in solution,
with a Svedberg coefﬁcient of 1.1 S corresponding to a
molecular weight of 19.5±0.4 kDa (Supplementary
Figure S3C). These results were further conﬁrmed by sedi-
mentation equilibrium analysis performed at two different
velocities, which notably agreed well with the previous
data (Supplementary Figure S3D).
Taking all the hydrodynamic data into account, we
conclude that the NT-SMG-912–180 domain did not form
any major aggregate, the predominant species in solution
being a monomer, at medium-high as well as low ionic
strength conditions.
A
B C
Figure 2. Expression and puriﬁcation of NT-SMG-912–180 in E. coli. (A) SDS–PAGE of three different constructs assayed to produce a soluble
fragment of NT-SMG-9. Left, N-terminal hexahistidine tag (pRHT vector); middle, periplasmic secretion vector (pRHO vector); and right, GST
fusion protein (pGEX-6p-2 vector). The total cell extract right before induction (column T0), 5 h after induction with 1mM IPTG (column T5) and
the soluble fraction after sonication of the T5 sample (column S), are shown. For the periplasmic construct the supernatant (column SN) of the
culture of T5 is shown, since the periplasmic space of E .coli is very leaky, over-expressed proteins can be easily localized in the supernatant of the
centrifuged culture. Lastly, in those two constructs where some expression was detected, the elution from an in-batch incubation of the supernatant
(periplasmic secretion construction) or the soluble fraction of T5 (GST-fusion construction) with HisTrap resin or GST–sepharose resin (column O),
are shown. The pull-down protein in the GST-NT-SMG-9 construct is labelled. (B) SDS–PAGE of a puriﬁed NT-SMG-912–180 after the ﬁrst
GST-trap column before (column NC) and after a 4 h digestion (column C) with 3C protease. (C) Final preparation after applying the puriﬁcation
protocol described in the text.
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The N-terminal domain of SMG-9 is an intrinsically
disordered region
Recent studies suggest that IDRs do not show uniform
structural properties, but their structure ranges from a
fully unstructured protein (‘random coils’) to partially
structured regions (‘pre-molten globule’) and more
‘folded’ proteins containing some elements of secondary
structure (‘molten globule’) (19,20). Proteins in the ﬁrst
group show no secondary structure at all as well as hydro-
dynamic dimensions like those of coiled-coils. In contrast,
pre-molten globules present a core of secondary structure,
although less dense than that found in structured proteins.
To gain insight into the structural properties of NT-SMG-
912–180 we investigated its secondary structure content
using two spectroscopic techniques, ultraviolet-circular di-
chroism (UV–CD) and ﬂuorescence spectroscopy
(Figure 3). Whereas completely unfolded polypeptides
are characterized by a well-deﬁned CD spectrum with a
minimum in the vicinity of 200 nm and an ellipticity close
to zero in the vicinity of 222 nm, the CD-spectra of
NT-SMG-912–180 showed a minimum at 205 nm and
negative values of ellipticity from 235 to 200 nm
(Figure 3A). This suggested the presence of certain
content in secondary structure. In addition, ﬂuorescence
spectra with an excitation wavelength of 295 nm revealed a
signiﬁcant increase in the ﬂuorescence emission upon de-
naturation of NT-SMG-912–180 using 6M guanidinium
hydrochloride compared to native conditions
(Figure 3B), strongly suggesting the presence of a certain
degree of secondary structure quenching the ﬂuorescence
of the two tryptophans of NT-SMG-912–180 in the native
protein.
NMR spectroscopy was performed to deﬁnitively deter-
mine the presence of an IDR at the N-terminus of SMG-9.
A 1H 1D spectrum of NT-SMG-912–180 showed two
groups of signals, a ﬁrst group of thin, well-resolved
peaks (6.5–8 ppm) and a group of superposed signals
accumulating between 8 and 8.5 ppm (Figure 4A). This
spectrum would be compatible with an unfolded polypep-
tide, being the ﬁrst group of sharp peaks those signals
corresponding to the ﬂexible lateral side chains and the
aromatic protons whereas the N–H backbone would
appear as those signals between 8 and 8.5 ppm. We also
performed 1H-15N-HSQC 2D experiments after labelling
NT-SMG-912–180 with 15N (Figure 4B), and we found that
the majority of the signals attributable to the N-H
backbone overlapped within a very narrow 1H chemical
shift, ranging from 7.75 to 8.5 ppm. This is a typical
spectrum for intrinsically disordered regions, where
deﬁned signals (in contrast to aggregated protein) are
concentrated in a narrow range (in contrast to folded
proteins). Signals of the two tryptophans present in
NT-SMG-912–180 were detected at 10.25, 128.89 ppm and
10.1, 127.48 ppm, 1H, 15N chemical shifts, respectively.
These chemical shifts are characteristic of solvent
exposed tryptophan residues as the amino acids of a dis-
ordered protein. In addition, the HSQC spectrum showed
several well-dispersed peaks typical of a folded structure,
suggesting the presence of some residual structure as pre-
viously suggested by CD and ﬂuorescence spectroscopy
data.
The N- and C-terminal domains of SMG-9 are required
to maintain the integrity of the SMG1C complex
We examined the relevance of the two domains of SMG-9
to maintain the integrity of the SMG-1:SMG-8:SMG-9
complex in cells. For this purpose, we expressed
full-length SMG-9 and fragments comprising the
N-terminal (NT-SMG-92–181) and C-terminal (CT-SMG-
9185–520) domains as SBP (Streptavidin Binding Peptide)
tagged fusion proteins in 293T cells. To avoid the inter-
ference of endogenous SMG-9, this protein was down
regulated using RNA interference targeted to
30-untranslated region of SMG-9. The expressed proteins
were bound to Streptavidin-beads in presence of RNaseA,
to remove interactions mediated by RNA, eluted and the
presence of SMG-1 and SMG-8 in the pull-downed
material tested by western blotting (Figure 5B). Whereas
Figure 3. Spectroscopic analyses of NT-SMG-912–180. (A) Far
UV-circular dichroism spectrum of NT-SMG-912–180. (B) Fluorescence
spectra of NT-SMG-912–180 in 50mM phosphate buffer and 50mM
NaCl (black circles) and in the same buffer but in the presence of
6M Guanidinium hydrochloride (white circles).
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each product was adequately expressed, only full-length
SMG-9 co-puriﬁed with SMG-1 and SMG-8 in presence
of RNaseA. These experiments indicated that both the N-
and C-terminal domains of SMG-9 are necessary for the
integrity of the SMG1C complex. To map the requirement
of SMG-9 for these interactions more precisely, in a
separate set of experiments, we simultaneously tested
two C-terminal constructs comprising residues 185–520
(CT-SMG-9185–520) and 175–520 (CT-SMG-9175–520)
tagged with SBP. SBP-pull-downs conﬁrmed that
CT-SMG-9185–520 was not capable of recognizing
SMG-1 or SMG-8. Interestingly, CT-SMG-9175–520,
where a small N-terminal segment ﬂanking the
C-terminal domain was incorporated, was sufﬁcient to
recognize SMG-8 at a similar level than full-length
SMG-9 (Figure 5C), whereas the recognition of SMG-1
was heavily impaired. These results strongly suggested
that CT-SMG-9 is directly responsible for the recognition
of SMG-8 whereas contributions of the N- and C-terminal
domains of SMG-9 are required to bind SMG-1.
The experiment described earlier was performed after
simultaneous co-transfection of full-length HA-tagged
SMG-9 and the SBP-tagged constructs, and surprisingly
the pull-downs revealed that the full-length and two
C-terminal constructs of SMG-9 tested were interacting
with full-length HA-SMG-9. Unexpectedly, CT-SMG-
9185–520 was forming a tight complex with full-length
SMG-9, devoid of SMG-1 and SMG-8, in striking
contrast with the behaviour of full length SMG-9 that
reproducibly pulls downs a signiﬁcant amount of
SMG-1 and SMG-8 (Figure 5C). In addition, full length
SBP-SMG-9 was found to interact with full length
HA-SMG-9, indicating that the association between
SMG-9 molecules takes place also in the context of the
full protein (Figure 5C). Hence, the existence of putative
SMG-9 oligomers was further investigated.
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Figure 4. NMR spectroscopy analysis of NT-SMG-912–180. (A) 1H monodimensional spectrum of NT-SMG-912–180 showing the overlapping of
signals in a narrow chemical shift in a range centered at 8.25 ppm. (B) 1H-15N HSQC spectrum of 15N-labelled NT-SMG-912–180 unambiguously
identiﬁed this domain as inherently unstructured due to the absence of well dispersed cross peaks. The presence of well-resolved peaks and the
absence of dispersion discarded any non-speciﬁc aggregation.
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SMG-9 assembles into stable oligomers with SMG-9
(homo-oligomers) and SMG-8 (hetero-oligomers) that are
not part of SMG1C
V5-tagged NT-SMG-92–181, or CT-SMG-9182–520 or full
length SMG-9 were co-expressed with SBP-tagged
CT-SMG-9185–520 in 293T cells (Figure 5D). Pull downs
by V5 antibody revealed a signiﬁcant interaction between
V5-tagged CT-SMG-9182–520 and SBP-tagged CT-SMG-
9185–520, indicating that the C-terminal region of SMG-9
strongly contributes to its self-association (Figure 5D).
However, we failed to detect binding between NT-SMG-
92–181 and CT-SMG-9185–520 (Figure 5D) and between
V5-tagged NT-SMG-92–181 and SBP-tagged NT-SMG-
92–181 (data not shown). These results correlate with the
ﬁnding that recombinant NT-SMG-912–180 behaved as a
monomer (Supplementary Figure S3).
The above experiments implied that SMG-9 could
assemble other complexes besides SMG1C and we
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Figure 5. Effect of NT-SMG-9 and CT-SMG-9 truncation in SMG1C assembly. (A) Schematic structures of SMG-9 construct. (B) 293T cells were
transfected with the SMG-9 plasmids shown above together with plasmid expressing the siRNA targeted to 30-UTR of SMG-9. (C) 293T cells were
transfected with the SBP-tagged-SMG-9 plasmids shown above together with the HA-tagged-SMG-9 plasmid. The cells were lysed and pull downed
with the streptavidn sepharose in presence of RNaseA. Pull downed products or cell lysates (input) were then probed with the antibodies shown on
the right. (D) 293T cells were transfected with the V5-tagged-SMG-9 plasmids shown above together with the SBP-tagged-CT-SMG-9185–520 plasmid.
The cells were lysed and immunoprecipitated with anti-V5 antibodies in presence of RNaseA. Immunoprecipitated products or cell lysates (input)
were then probed with the antibodies shown on the right. ‘Vector’ indicates an empty vector.
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sought a further conﬁrmation by partially resolving
SMG-9 complexes by size exclusion chromatography
(Figure 6). HeLa cell extracts were fractionated by gel ﬁl-
tration and the fractions analysed by denaturing electro-
phoresis and western blotting. As controls, we used
markers of molecular weight (Figure 6A, top line),
mTOR, a PIKK member that migrates as a monomer
(290 kDa) and as a 0.7–0.8MDa multi-protein complex
(22), and aPKC (78 kDa). In addition to a well-resolved
peak corresponding to SMG1C and comprising SMG-1,
SMG-8 and SMG-9, SMG-9 was detected in two add-
itional peaks. One, composed only of SMG-9 (monomer,
60 kDa) clearly migrated as a homo-oligomer rather
than a monomer, and the apparent molecular weight
correlated with the dimeric species previously detected
by pull-down assays. In addition, a second peak contain-
ing SMG-9 migrated as a larger complex, which exactly
co-migrated with SMG-8 as 400 kDa complexes, a
strong indication of an SMG-8:SMG-9 complex. These
results suggested that SMG-9 has biological functions
beyond SMG1C, also maybe regulating SMG1C
assembly by means of several SMG-9-containing
sub-complexes.
Accordingly, we found that interfering with SMG-9 by
expressing NT-SMG-9 and CT-SMG-9 truncated
products, affected the normal response of cells to
genotoxic stress and increased susceptibility to apoptosis
(Supplementary Figure S4 and Supplementary Data), in
agreement with the role described for these complexes in
genome stability and apoptosis (3,13). HEK-293 cells
were transfected with vectors coding for full length
SMG-9, NT-SMG-9 or CT-SMG-9 fragments (see
Supplementary Data for details) and tested for suscepti-
bility to cisplatin, a DNA alkylating agent known to
cause cell apoptosis. Cis-platin treatment led to a
dose-dependent increase in cell apoptosis that was of
higher extent in cells over-expressing the N-terminal or
C-terminal domains of SMG-9 than in cells expressing
the full length protein or than in mock cells. This effect
was associated with reduction in pro-caspase-3 levels and
with increased processing of PARP-1.
DISCUSSION
The activities of the SMG1C complex, containing SMG-1,
SMG-8 and SMG-9 are essential for NMD in mammals
(12). SMG-8 and SMG-9 regulate the kinase activity of
SMG-1, and SMG-8 is also required to recruit SMG-1 to
the mRNA surveillance complex. It has been proposed
that the SMG1C complex could control NMD by inhibit-
ing SMG-1-mediated Upf1 phosphorylation until a
PTC-containing mRNA is properly recognized (12).
Here, we show that SMG-9 comprises an N-terminal
domain with the characteristic features of the so-called
intrinsically disordered regions (IDRs) and a well-folded
C-terminal domain (12). We demonstrate that both the
N-terminal IDR and the C-terminal domain of SMG-9
are required for the integrity of the SMG1C complex.
Both domains are implicated in SMG-1 binding, since
removal of either domain disrupts, totally or partially,
the interaction of SMG-9 with SMG-1. On the other
hand, SMG-9 was found to interact with SMG-8 mostly
through its C-terminal domain.
We have puriﬁed a protein comprising the N-terminal
domain and several biophysical approaches (gel ﬁltration
chromatography, analytical ultracentrifugation, CD, and
UV-spectroscopy) have conﬁrmed unambiguously that
this region behaves as a compact 20 kDa domain with
the paradigmatic characteristics of unstructured domains
as well as a limited presence of secondary structure.
Whereas misfolded proteins usually aggregate due to the
exposure of the hydrophobic residues that form the core
of folded domains, an intrinsically disordered protein is
soluble even in the presence of low or no secondary struc-
ture due to the unusual composition of their sequences,
enriched in polar and charged residues (19,20). The results
obtained by NMR spectroscopy represent the formal
proof that the N-terminus of SMG-9 is an IDR. The ‘sig-
nature’ of the mono and bi-dimensional spectra of
NT-SMG-9 is that typical of this group of proteins with
deﬁned signals concentrated in a narrow range (19,20).
Furthermore, the combination of NMR data and the spec-
troscopy studies suggests that the conformation of the
NT-SMG-9 domain most likely ﬁts into the category of
intrinsically unstructured proteins termed ‘pre-molten
globules’, where a limited degree of secondary structure
could be localized.
There is a growing interest in the functional roles of
intrinsically disordered regions and intrinsically dis-
ordered proteins, since these seem to play important
roles in cellular functions such as transcription regulation,
genome surveillance, chromatin remodeling or mRNA
processing (19,20). Algorithms designed to detect these
domains in the primary structure of proteins suggests
that the number and functional relevance of IDRs
increase with the complexity of the organism. It has
been estimated that 25% of the total number of proteins
in complex eukaryotic genomes may be totally disordered
and 50% could contain at least one disordered region.
IDRs seem to be adequately suited for protein–protein
interactions in large macromolecular machines involving
very speciﬁc but transient interactions. These domains
seem to provide high speciﬁcity sustained in a large area
of contact but moderate afﬁnities facilitating interchange
of partners. A recent description of the interaction
between Upf1 and the C-terminal domain of Upf2
revealed that this domain of Upf2 is intrinsically dis-
ordered and the elements of secondary structure are only
co-folded upon recognition of Upf1 (23). Given the com-
plexity of NMD and more generally of the mRNA pro-
cessing machinery, intrinsically disordered regions, as the
one presently described for SMG-9, could be present in
other components of mRNA processing pathways.
We have found that SMG-9 assembles into several
complexes apart from SMG1C, SMG-9:SMG-9
complexes, and most likely also SMG-8:SMG-9
complexes. The ﬁnding that SMG-9 dimers could be
isolated by gel ﬁltration (Figure 6) and that a partially
truncated dimer (CT-SMG-9185–520:SMG-9) is completely
free of SMG-1 and SMG-8 (Figure 5C) suggests that
SMG-9 dimers are not a component of the SMG1C
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complex. This ﬁnding is in striking contrast to the
well-characterized behaviour of SMG-9, which pull
downs SMG-1 and SMG-8 indicating that SMG-9 is a
component of SMG1C (12). On the other hand, the de-
tection of SMG-8:SMG-9 complexes indicate that an as-
sociation between these two proteins may also regulate the
interaction with SMG-1 and the assembly of SMG1C.
We propose that several SMG-9 containing complexes
that do not contain SMG-1 could potentially have bio-
logical functions apart from SMG1C. Thus, SMG-1 has
been shown to participate in the cellular stress response
(14,16–18), and we ﬁnd that the expression of truncated
versions of SMG-9 increased the susceptibility to apoptosis
(Supplementary Figure S4). In addition, we speculate that
SMG-9:SMG-9 and, probably, SMG-8:SMG-9 complexes
could function as intermediaries mediating the assembly of
SMG1C. One possibility could be that the self-association
between SMG-9 molecules through the C-terminal
domains, could repress the interaction with SMG-8 and/
or SMG-1, as proposed for other signalling molecules
(Figure 7). For instance, ATM, a member of the PIKK
family of kinases, is activated by a transition from an in-
hibited dimer under normal conditions converting into an
active monomer after DNA damage, a transition requiring
phosphorylation of Ser1981 (24). A possible regulatory
event driving the transitions between the homo-oligomeric
and SMG1C-assembled states of SMG-9 could be phos-
phorylation. Several conserved residues of SMG-9 located
within the N-terminal disordered and the C-terminal
domains are speciﬁcally phosphorylated by SMG-1 (12)
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Figure 6. Several SMG-9-containing complexes can be isolated. (A and B) Size exclusion chromatography of SMG-1, SMG-8 and SMG-9 containing
complexes. Fractions were run in SDS gels and the presence of either protein tested by western blot using anti-bodies speciﬁc to each component.
As molecular weight markers, commercial markers (location of their elution peaks indicated in top line), mTOR (290 kDa and 0.7MDa) and aPKC
(78 kDa) were used.
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(Akio Yamashita and Shigeo Ohno unpublished data).
Under certain circumstances, SMG-9 would be activated,
interacting with SMG-8 by means of its C-terminal
domain. This SMG-8:SMG-9 complex could be the
building block to assemble SMG1C. At this stage, we
cannot completely rule out that SMG-9 could also be a
dimer within SMG1C, although current data favours a
model with an equimolar SMG-1:SMG-8:SMG-9
complex (12). An assembly pathway of SMG1C regulated
at the level of SMG-9 and SMG-8 would allow the tuning
of the biological functions of SMG1C with the rest of the
NMD machinery to either restrain or promote the activa-
tion of SMG-1. The N-terminal disordered domain of
SMG-9 participates in the recognition of SMG-1, and it
would be the characteristic malleability of IDRs an
adequate structural property to allow the transit of
SMG-9 through these distinct macromolecular complexes.
SMG-9 could therefore appear as an important controller
of SMG-1 by regulating the formation of SMG1C and
consequently the activation of its kinase activity towards
Upf1(12).
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